The relation between oxidant and antioxidant parameters and severity of acute coronary syndromes

Acta Cardiologica

Volumn 62, Issue 4, 2007, Pages 373-380

  Serdar, Zehra ^a   Serdar, Akin ^a   Altin, Aysun ^a   Eryilmaz, Ufuk ^a   Albayrak, Sezgin ^a  

^a ULUDAG UNIVERSITY   (Turkey)

Author keywords

Acute coronary syndrome; Carotenoids; Malondialdehyde; Paraoxonase; Protein carbonyls; Total sialic acid; Vitamin C; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; APOLIPOPROTEIN A1; APOLIPOPROTEIN B; ARYLDIALKYLPHOSPHATASE; ARYLESTERASE; ASCORBIC ACID; BIOCHEMICAL MARKER; CARBONYL DERIVATIVE; CAROTENOID; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MALONALDEHYDE; OXIDIZING AGENT; SIALIC ACID; TRIACYLGLYCEROL;

ACUTE CORONARY SYNDROME; ADULT; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HEART INFARCTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LIPID PEROXIDATION; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; PARAMETER; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; RISK FACTOR; SPECTROFLUOROMETRY; ST SEGMENT ELEVATION; UNSTABLE ANGINA PECTORIS; VITAMIN BLOOD LEVEL;

ACUTE CORONARY SYNDROME; AGED; ANALYSIS OF VARIANCE; ANGINA, UNSTABLE; ANTIOXIDANTS; ARYLDIALKYLPHOSPHATASE; BIOLOGICAL MARKERS; CARBOXYLIC ESTER HYDROLASES; CASE-CONTROL STUDIES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; FOLLOW-UP STUDIES; HUMANS; LIPID PEROXIDATION; MALE; MALONDIALDEHYDE; MIDDLE AGED; MYOCARDIAL INFARCTION; N-ACETYLNEURAMINIC ACID; OXIDANTS; OXIDATIVE STRESS; PROTEIN CARBONYLATION; SEVERITY OF ILLNESS INDEX;

EID: 34548161430     PISSN: 00015385     EISSN: None     Source Type: Journal    
DOI: 10.2143/AC.62.4.2022281     Document Type: Article

References (48)

1. Holschermann H, Tillmanns H, Bode C. Pathophysiology of acute coronary syndrome. Hamostaseologie 2006; 26: 99-103.
2. Fox KAA. Management of acute coronary syndromes: an update. Heart 2004; 90: 698-706.
3. Elahi MM, Matata BM. Free radicals in blood: evolving concepts in the mechanism of ischemic heart disease. Arch Biochem Biophys 2006; 450: 78-88.
4. Halliwell B, Gutteridge JM, Cross CE. Free radicals, antioxidants, and human disease: where are we now? J Lab Clin Med 1992; 119: 598-620.
5. Fuster V, Badimon L, Badimon JJ, Chesebro JH. The pathogenesis of coronary artery disease and the acute coronary syndromes. N Engl J Med 1992; 326: 310-8.
6. Steinberg D, Witztum JL. Lipoproteins and atherogenesis. JAMA 1990; 264: 3047-52.
7. Stadtman ER, Levine RL. Protein oxidation. Ann N Y Acad Sci 2000; 899: 191-208.
8. Ehara S, Ueda M, Naruko T, Haze K, Itoh A, Otsuka M, Komatsu R, Matsuo T, Itabe H, Takano T, Tsukamoto Y, Yoshiyama M, Takeuchi K, Yoshikawa J, Becker AE. Elevated levels of oxidized low density lipoprotein show a positive relationship with the severity of acute coronary syndromes. Circulation 2001; 103: 1955-60.
9. Skvarilova M, Bulava A, Stejskal D, Adamovs.ka S, Bartek J. Increased level of advanced oxidation products (AOPP) as a marker of oxidative stress in patients with acute coronary syndrome. Biomed Pap 2005; 149: 83-7.
10. Lindberg G, Rastam L, Gullberg B, Lundblad A, Nilsson-Ehle P, Hanson BS. Serum concentrations of total sialic acid and sialoglycoproteins in relation to coronary heart disease risk markers. Atherosclerosis 1993; 103: 123-9.
11. Crook M, Haq M, Haq S, Tutt P. Plasma sialic acid and acute-phase proteins in patients with myocardial infarction. Angiology 1994; 45: 709-15.
12. Berkan O, Sagban M. Sialic acid or troponin T to detect perioperative myocardial damage in patients undergoing elective coronary artery bypass grafting. Circ J 2002; 66: 1019-23.
13. Gokmen SS, Kilicli G, Ozcelik F, Gulen S. Serum total and lipid-bound sialic acid levels following acute myocardial infarction. Clin Chem Lab Med 2000; 38: 1249-55.
14. Allain P, Olivier E, Le Bouil A, Benoit C, Geslin P, Tadei A. Increase of sialic acid concentration in the plasma of patients with coronary disease. Presse Med 1996; 25: 96-8.
15. Libby P. Current concepts of the pathogenesis of the acute coronary syndromes. Circulation 2001; 104: 365-72.
16. Devasagayam TP, Tilak JC, Boloor KK, Sane KS, Ghaskadbi SS, Lele RD. Free radicals and antioxidants in human health: current status and future prospects. J Assoc Physicians India 2004; 52: 794-804.
17. Durrington PN, Mackness B, Mackness MI. Paraoxonase and atherosclerosis. Arterioscier Tromb Vase Biol 2001; 21: 473-80.
18. Gan KN, Smolen A, Eckerson H.W, La Du BN. Purification of human serum paraoxonase/arylesterase: Evidence for one esterase catalyzing both activities. Drug Metab Dispos 1991; 19: 100-6.
19. Aviram M, Rosenblat M, Bisgaier CL. Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase. J Clin Invest 1998; 101: 1581-90.
20. Ng CJ, Shih DM, Hama SY, Villa N, Navab M, Reddy ST. The paraoxonase gene family and atherosclerosis. Free Radic Biol Med 2005; 38: 153-63.
21. Senthil S, Veerappan RM, Ramakrishna Rao M, Pugalendi KV. Oxidative stress and antioxidants in patients with cardiogenic shock complicating acute myocardial infarction. Clin Chim Acta 2004; 348: 131-7.
22. Ayub A, Mackness MI, Arrol S, Mackness B, Patel J, Durrington PN. Serum paraoxonase after myocardial infarction. Arterioscier Thromb Vasc Biol 1999; 19: 330-5.
23. Yesilbursa D, Serdar Z, Dirican M, Serdar A, Gullulu S, Cordan J. Susceptibility of apolipoprotein B-containing lipoproteins to oxidation and antioxidant status in acute coronary syndromes. Clin Cardiol 2000; 23: 655-8.
24. Kabaroglu C, Mutaf I, Boydak B, Ozmen D, Habif S, Erdener D, Parildar Z, Bayindir O. Association between serum paraoxonase activity and oxidative stress in acute coronary syndromes. Acta Cardiol 2004; 59: 606-11.
25. Greenland P, Smith SC, Grundy SM. Improving coronary heart disease assessment in asymptomatic people. Role of traditional risk factors and noninvasive cardiovascular tests. Circulation 2001; 104: 1863-7.
26. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of preparative ultracentrifuge. Clin Chem 1972; 18: 499-502.
27. Sydow G. A simplified quick method for determination of sialic acid in serum. Biomed Biochem Acta 1985; 44: 1721.
28. Young IS, Trimble ER. Measurement of malondialdehyde in plasma by high performance liquid chromatography with fluorimetric detection. Ann Clin Biochem 1991; 28: 504-8.
29. Reznick AZ, Packer L. Oxidative damage to proteins: spectrophotometric method for carbonyl assay. Methods Enzymol 1994; 233: 357-63.
30. Eckerson HW, Wyte MC, La Du BN. The human serum paraoxonase/arylesterase polymorphism. Am J Hum Genet 1983; 35: 1126-38.
31. Haagen L, Brock A. A new automated method for phenotyping arylesterase (E.C.3.1.1.2.) based upon inhibition of enzymatic hydrolysis of 4-nitrophenyl acetate by phenyl acetate. Eur J Clin Chem Clin Biochem 1992; 30: 391-5.
32. Teissier E, Walters-Laporte E, Duhem C, Luc G, Fruchart JC, Duriez P. Rapid quantification of α-tocopherol in plasma and low- and high-density lipoproteins. Clin Chem 1996; 42: 430-5.
33. McCormick DB, Greene HL. Vitamins. In: Burtis CA, Ashwood ER, eds. Tietz Textbook of Clinical Chemistry. W.B. Saunders Co, Philadelphia, 1994: 313-4.
34. Neeld JB, Pearson WN. Macro-and micromethods for determination of serum vitamin A using trifluoroacetic acid. J Nutr 1963; 79: 454-62.
35. Stocker R, Keaney JF. Role of oxidative modifications in atherosclerosis. Physiol Rev 2004; 84: 1381-478.
36. Nand N, Budhiraja N, Singh GP, Sharma M, Aggarwal HK. Lipid peroxidation and vitamin E in ischemic heart disease. J Assoc Physicians India 1997; 45: 839-42.
37. Fainaru O, Fainaru M, Assali AR, Pinchuk I, Lichtenberg D. Acute myocardial infarction is associated with increased susceptibility of serum lipids to copper-induced peroxidation in vitro. Clin Cardiol 2002; 25: 63-8.
38. Cikim G, Canatan H, Gursu MF, Gulcu F, Baydas G, Kilicoglu AE. Levels of zinc and lipid peroxidation in acute coronary syndrome. Biol Trace Elem Res 2003; 96: 61-9.
39. Chevion M, Berenshtein E, Stadtman ER. Human studies related to protein oxidation: Protein carbonyl content as a marker of damage. Free Rad Res 2000; 33: 99-108.
40. Kaneda H, Taguchi J, Ogasawara K, Aizawa T, Ohno M. Increased level of advanced oxidation protein products in patients with coronary artery disease. Atherosclerosis 2002; 162: 221-5.
41. Tatarkova Z, Kaplan P, Matejovicova M, Lehotsky J, Dobrota D, Flameng W. Effect of ischemia and reperfusion on protein oxidation in isolated rabbit hearts. Physiol Res 2005; 54: 185-91.
42. Sonmez H, Suer S, Ulutin T, Kokoglu E, Ucisik N. The relationship of various factors in the pathogenesis of atherosclerosis. Clin Appl Thrombosis/Hemostasis 1998; 4: 105-10.
43. Gokmen SS, Kazezoglu C, Sunar B, Ozcelik F, Gungor O, Yorulmaz F, Gulen S. Relationship between serum sialic acids, sialic acid-rich inflammation-sensitive proteins and cell damage in patients with acute myocardial infarction. Clin Chem Lab Med 2006; 44: 199-206.
44. Herbaczynska-Cedro K, Kosiewicz-Wasek B, Cedro K, Wasek W, Panczenko-Kresowska B, Wartanowicz M. Supplementation with vitamins C and E suppresses leukocyte oxygen free radical production in patients with myocardial infarction. Eur Heart J 1995; 16: 1044-9.
45. Singh RB, Niaz MA, Sharma JP, Kumar R, Bishnoi I, Begom R. Plasma levels of antioxidant vitamins and oxidative stress in patients with acute myocardial infarction. Acta Cardiol 1994; 49: 441-52.
46. Gasparetto C, Malinverno A, Culacciati D, Gritti D, Prosperini PG, Specchia G, Ricevuti G. Antioxidant vitamins reduce oxidative stress and ventricular remodeling in patients with acute myocardial infarction. Int J Immunopathol Pharmacol 2005; 18: 487-96.
47. Getz GS, Reardon CA. Paraoxonase, a cardioprotective enzyme: continuing issues. Curr Opin Lipidol 2004; 15: 261-7.
48. Azarsiz E, Kayikcioglu M, Payzin S, Sozmen EY. PON1 activities and oxidative markers of LDL in patients with angiographically proven coronary artery disease. Int J Cardiol 2003; 91: 43-51.